Remove pharmaceutical-product-positioning
article thumbnail

Pharmaceutical product positioning

eMediWrite

The process of giving a pharmaceutical product a unique identity on the market is called pharmaceutical product positioning. It entails recognising the special qualities and advantages of your product and conveying them to the intended market in a way that sets it apart from rival goods.

article thumbnail

CDMO acquires Meppel facility from Astellas

European Pharmaceutical Review

Delpharm has acquired the Meppel pharmaceutical manufacturing facility in the Netherlands from Astellas. The acquisition will strengthen the CDMO’s position in the Netherlands, where it already owns a manufacturing facility in Bladel and an injectable drug development centre in Leiden. billion in 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UK advanced therapies to get £17.9 million boost

European Pharmaceutical Review

million strategic initiative is set to support UK advanced therapy medicinal product (ATMP) clinical trials, and help the region maintain its position as a leader in clinical research. Maintaining the UK’s position in clinical research “This investment reaffirms the UK’s position as a global leader in clinical research.

article thumbnail

CHMP meeting highlights: April 2024

European Pharmaceutical Review

The Committee for Human Medicinal Products (CHMP) has recommended the approval of new eight medicines. A positive opinion of a marketing authorisation was granted for Altuvoct (efanesoctocog alfa), as a treatment and prophylaxis of bleeding in patients with the rare blood disorder haemophilia A.

article thumbnail

Strong growth for Sweden’s pharmaceutical exports

European Pharmaceutical Review

billion, exports of pharmaceuticals reached a total of 7.3 Value of Swedish pharmaceutical exports Swedish pharmaceuticals exports are currently “significantly larger” than exports of iron and steel. As such, Swedish pharmaceutical exports are expected to continue their positive development, SwedenBIO asserted.

article thumbnail

AbbVie breaks ground on new R&D centre

European Pharmaceutical Review

Construction of the LUnA research building means AbbVie Germany “can conduct cutting-edge research at our site in the long term,” stated Martin Gastens , Vice President, Biologics Drug Product Development and Managing Director R&D, AbbVie Germany. The new R&D building in Germany is expected to completed in 2027.

article thumbnail

Dr. Reddy’s Laboratories Ltd.-Walk-In Drive for Multiple Positions On 8th Jan’ 2023

Pharma Pathway

-Walk-In Drive for Multiple Positions On 8th Jan’ 2023. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three business-Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Job Description.